| Literature DB >> 28725729 |
Corey A Theriot1, Christian M Westby2, Jennifer L L Morgan3, Sara R Zwart2, Susana B Zanello2.
Abstract
Radiation exposure in combination with other space environmental factors including microgravity, nutritional status, and deconditioning is a concern for long-duration space exploration missions. Astronauts experience altered iron homeostasis due to adaptations to microgravity and an iron-rich food system. Iron intake reaches three to six times the recommended daily allowance due to the use of fortified foods on the International Space Station. Iron is associated with certain optic neuropathies and can potentiate oxidative stress. This study examined the response of eye and vascular tissue to gamma radiation exposure (3 Gy fractionated at 37.5 cGy per day every other day for 8 fractions) in rats fed an adequate-iron diet or a high-iron diet. Twelve-week-old Sprague-Dawley rats were assigned to one of four experimental groups: adequate-iron diet/no radiation (CON), high-iron diet/no radiation (IRON), adequate-iron diet/radiation (RAD), and high-iron diet/radiation (IRON+RAD). Animals were maintained on the corresponding iron diet for 2 weeks before radiation exposure. As previously published, the high-iron diet resulted in elevated blood and liver iron levels. Dietary iron overload altered the radiation response observed in serum analytes, as evidenced by a significant increase in catalase levels and smaller decrease in glutathione peroxidase and total antioxidant capacity levels. 8-OHdG immunostaining, showed increased intensity in the retina after radiation exposure. Gene expression profiles of retinal and aortic vascular samples suggested an interaction between the response to radiation and high dietary iron. This study suggests that the combination of gamma radiation and high dietary iron has deleterious effects on retinal and vascular health and physiology.Entities:
Year: 2016 PMID: 28725729 PMCID: PMC5515516 DOI: 10.1038/npjmgrav.2016.14
Source DB: PubMed Journal: NPJ Microgravity ISSN: 2373-8065 Impact factor: 4.415
Figure 1Effects of radiation and dietary iron on serum analyte levels. The white bar for each analyte is the percentage change in its level in the RAD group relative to its level in the CON group. The black bar for each analyte is the percentage change in its level in the IRON+RAD group relative to its level in the IRON group. *Main effect of radiation. †Pairwise comparison between columns is different P<0.05. Raw data for these analytes have been previously reported.[39] CON, adequate-iron diet/no radiation; CRP, C-reactive protein; GPx, glutathione peroxidase; IRON, high-iron diet/no radiation; RAD, adequate-iron diet/radiation; TAC, total antioxidant capacity.
Figure 2Effects of dietary iron and radiation on 8-OHdG immunoreactivity in retina sections. 8-OHdG immunoreactivity was determined in individual retinal neuronal layers (a–c) and in all retina layers combined (d) for the four groups of rats. Horizontal lines represent the mean immunoreactivity for each rat group (n=3 rats per group) and vertical bars indicate the s.d. Eight individual images from each biological sample were analyzed and their averages are represented by the symbols (circles, squares, up triangles, and down triangles) in the plots.
List of 27 genes analyzed in the retina by qRT-PCR for expression level
| ATG12 (autophagy-related protein 12) | 84.58±33.00 | 108.41±28.60 | 52.56±8.83 | 67.55±14.14 | |||
| Bcl2 (B-cell lymphoma 2) | 3.19±2.00 | 2.44±0.82 | 1.79±0.59 | 1.50±0.25 | |||
| Casp1 (caspase 1) | 1.45±0.00 | 1.28±0.31 | 1.59±0.47 | 1.38±0.24 | |||
| Casp2 (caspase 2) | 13.38±7.00 | 15.60±4.50 | 6.06±3.34 | 10.35±2.26 | |||
| Casp3 (caspase 3) | 3.65±2.00 | 4.83±2.12 | 2.14±1.19 | 2.19±0.44 | |||
| CLU (clusterin) | 728.83±254.00 | 789.68±206.88 | 601.21±196.35 | 589.38±193.74 | |||
| HiF1 (hypoxia-indicible factor) | 265.43±193.00 | 443.87±331.98 | 183.64±45.33 | 185.27±113.26 | |||
| Cp1 (ceruloplasmin) | 109.19±48.00 | 95.35±51.05 | 70.17±8.27 | 92.02±46.88 | |||
| FtH1 (Ferritin, Heavy) | 2.58±0.58 | 2.89±0.53 | 2.36±0.39 | 2.82±1.31 | |||
| FtL1 (Ferritin, Light) | 57.44±45.00 | 101.68±73.90 | 183.05±173.98 | 280.95±226.71 | |||
| Tf1 (transferrin 1) | 3.21±1.14 | 3.26±2.32 | 2.40±7.34 | 3.55±2.04 | |||
| Egr1 (early growth response factor) | 28.26±33.00 | 20.44±23.24 | 28.41±32.77 | 15.02±8.19 | |||
| CFH (complement factor H) | 61.74±26.00 | 73.44±17.29 | 34.92±4.25 | 71.75±30.97 | |||
| TrkA (tyrosine kinase receptor type 1) | 13.10±7.00 | 7.46±4.48 | 6.41±3.26 | 10.21±5.72 | |||
| VEGF (vascular endothelial growth factor) | 6.67±5.00 | 9.21±8.63 | 3.49±0.76 | 4.94±2.08 | |||
| Gfap (glial fibrillary acidic protein) | 79.18±32.00 | 145.09±69.76 | 72.33±23.63 | 175.19±184.27 | |||
| Gndf (glial cell line derived neurotrophic factor) | 1.40±0.00 | 1.69±0.86 | 1.69±0.52 | 1.38±0.24 | |||
| Opn4 (melanopsin pigment) | 14.56±6.00 | 31.96±15.98 | 13.58±8.22 | 14.26±1.93 | |||
| Rho (rhodopsin pigment) | 10.86±13.00 | 9.54±8.78 | 10.39±8.71 | 31.45±54.70 | |||
| Hmox1 (heme oxygenase 1) | 7.08±2.39 | 4.67±1.32 | 8.08±1.31 | 14.70±2.20 | |||
| Nrf2 (nuclear factor like 2) | 14.33±8.21 | 14.81±11.15 | 5.72±2.18 | 16.61±5.39 | |||
| HSF1 (heat shock factor) | 50.57±15.93 | 53.66±17.22 | 25.50±4.36 | 28.23±7.22 | |||
| HSP27 (heat shock factor 27) | 188.86±182.80 | 193.51±204.24 | 489.15±213.76 | 276.19±235.35 | |||
| HSP70 (heat shock factor 70) | 1.40±0.36 | 1.76±0.85 | 1.59±0.47 | 1.45±0.24 | |||
| Sirt1 (Sirtuin 1) | 26.21±12.16 | 31.42±10.57 | 15.14±4.68 | 18.66±3.54 | |||
| SOD2 (Mitochondrial superoxide dismutase) | 168.39±83.41 | 152.27±113.83 | 100.78±22.94 | 230.01±177.47 | |||
Abbreviations: ANOVA, analysis of variance; ECM, extracellular matrix; IRON, high-iron diet/no radiation; IRON+RAD, high-iron diet/radiation; qRT-PCR, quantitative reverse transcription PCR; RAD, adequate-iron diet/radiation.
Expression level of 27 genes analyzed in the retina by qRT-PCR. The [(2−Δct)×1000] values for all genes investigated in the retina are listed. P values are based on a two-way ANOVA of the treatment effects calculated using Δct values.
Figure 3Radiation effects on gene expression in retina samples from rats on normal-iron or high-iron diets. Relative gene expression in retina samples, calculated using the ΔΔCt method, is presented as fold change associated with radiation (RAD versus CON groups for normal diet, IRON+RAD versus IRON groups for high-iron diet). All genes were considered to be upregulated by radiation if the relative value was above 1 and downregulated if the relative value was below 1. CON, adequate-iron diet/no radiation; IRON, high-iron diet/no radiation; RAD, adequate-iron diet/radiation.
List of 84 genes analyzed in the vasculature by qRT-PCR for expression level
| Cd44 | 0.22±0.14 | 0.16±0.14 | 0.38±0.54 | 1.52±2.87 | |||
| Cdh2 (cadherin 2) | 0.94±0.54 | 1.94±2.96 | 1.13±0.72 | 0.86±0.59 | |||
| Cdh3 (cadherin 3) | 1.48±1.00 | 1.16±1.05 | 1.54±1.03 | 5.28±8.58 | |||
| Cdh4 (cadherin 4) | 5.68±2.33 | 8.01±5.24 | 5.42±1.91 | 9.96±3.44 | |||
| Ncam1 (neural cell adhesion molecule 1) | 17.75±6.58 | 11.31±6.54 | 18.29±13.02 | 17.99±19.39 | |||
| Ncam2 (neural cell adhesion molecule 2) | 3.82±3.26 | 11.19±15.80 | 7.94±7.83 | 7.36±7.93 | |||
| Pecam1 (platelet/endothelial cell adhesion molecule 1) | 64.83±46.27 | 48.01±17.11 | 57.65±31.41 | 61.31±35.57 | |||
| Sele (selectin E) | 0.79±0.36 | 1.18±0.40 | 0.80±0.37 | 1.03±0.50 | |||
| Sell (selectin L) | 23.58±30.03 | 68.30±76.86 | 15.38±26.57 | 3.16±2.49 | |||
| Selp (selectin P) | 2.77±1.78 | 4.16±4.21 | 2.08±1.04 | 1.78±1.11 | |||
| Sgce (sarcoglycan, epsilon) | 33.81±12.87 | 31.92±14.23 | 36.11±10.18 | 35.19±12.49 | |||
| Syt1 (synaptotagmin I) | 6.43±8.60 | 3.76±1.60 | 9.87±9.61 | 11.55±18.56 | |||
| Cdh1 (cadherin 1) | 7.42±6.44 | 12.30±17.89 | 7.58±3.70 | 16.76±24.21 | |||
| Icam1 (intercellular adhesion molecule 1) | 5.91±3.83 | 8.72±5.54 | 5.71±2.34 | 5.67±1.45 | |||
| Vcam1 (vascular cell adhesion molecule 1) | 13.53±11.02 | 18.22±12.19 | 12.63±6.94 | 10.54±4.99 | |||
| Ctgf (connective tissue growth factor) | 76.28±31.49 | 127.38±131.22 | 74.40±25.76 | 140.60±40.54 | |||
| Itga2 (integrin, alpha 2) | 1.94±0.92 | 1.75±0.45 | 2.87±3.16 | 10.35±18.19 | |||
| Itga3 (integrin, alpha 3) | 9.68±4.60 | 9.13±4.10 | 10.46±4.94 | 17.99±11.27 | |||
| Itga4 (integrin, alpha 4) | 22.22±28.97 | 25.06±18.35 | 9.07±6.93 | 10.33±6.54 | |||
| Itga5 (integrin, alpha 5) | 44.29±33.89 | 35.03±33.56 | 27.99±15.51 | 31.69±23.39 | |||
| Itgad (integrin, alpha D) | 1.53±2.00 | 2.82±2.95 | 0.67±0.42 | 0.91±0.20 | |||
| Itgae (integrin, alpha E) | 12.48±4.00 | 13.06±6.31 | 10.41±3.36 | 13.83±10.93 | |||
| Itgal (integrin, alpha L) | 26.38±44.72 | 13.54±12.92 | 5.95±5.34 | 6.16±3.72 | |||
| Itgam (integrin, alpha M) | 0.76±0.39 | 0.84±0.64 | 0.73±0.31 | 0.87±0.41 | |||
| Itgav (integrin, alpha V) | 33.46±15.51 | 28.25±5.30 | 41.02±12.51 | 41.39±15.05 | |||
| Itgb1 (integrin, beta 1) | 182.48±69.60 | 204.01±104.91 | 216.72±39.17 | 246.25±75.48 | |||
| Itgb2 (integrin, beta 2) | 25.51±37.65 | 23.38±19.07 | 10.38±9.09 | 7.43±2.81 | |||
| Itgb3 (integrin, beta 3) | 8.07±3.45 | 21.37±36.73 | 8.28±5.25 | 23.14±22.54 | |||
| Itgb4 (integrin, beta 4) | 7.30±5.62 | 8.29±3.71 | 11.40±6.87 | 15.05±20.22 | |||
| Spp1 (secreted phosphoprotein 1) | 12.66±8.27 | 6.31±2.93 | 11.96±12.26 | 2.73±1.76 | |||
| Catna1 (catenin, alpha 1) | 60.83±31.70 | 32.35±14.23 | 57.39±25.88 | 62.54±41.35 | |||
| Ctnna2 (cadherin associated protein, alpha 2) | 0.38±0.52 | 0.66±0.47 | 0.87±1.18 | 0.70±1.11 | |||
| Cntn1 (contactin 1) | 1.47±2.23 | 0.75±0.44 | 1.02±0.74 | 1.08±1.02 | |||
| Ctnnb1 (cadherin associated protein, beta 1) | 71.13±29.93 | 63.09±17.46 | 78.80±11.97 | 119.46±45.09 | |||
| Emilin1 (eastin microfibril interfacer 1) | 4.63±1.56 | 11.11±17.14 | 4.51±2.28 | 7.38±4.06 | |||
| Fn1 (fibronectin 1) | 44.46±21.46 | 36.06±15.89 | 43.93±18.43 | 29.98±17.90 | |||
| Postn (osteoblast specific factor) | 112.89±34.70 | 159.26±90.42 | 155.67±83.42 | 190.23±158.34 | |||
| Tgfbi (transforming growth factor beta) | 9.35±7.94 | 9.56±4.65 | 8.05±2.75 | 8.66±9.84 | |||
| Thbs1 (thrombospondin 1) | 5.67±3.09 | 8.35±2.36 | 11.22±9.78 | 6.26±2.71 | |||
| Thbs2 (thrombospondin 2) | 6.51±1.20 | 5.80±3.53 | 6.48±3.99 | 6.50±3.74 | |||
| Vtn (vitronectin) | 9.94±6.06 | 6.69±4.68 | 11.10±5.35 | 9.96±6.79 | |||
| Ecm1 (extracellular matrix protein 1) | 15.23±9.63 | 3.82±2.23 | 8.26±4.32 | 9.21±6.82 | |||
| Entpd1 (ectonucleoside triphosphate diphosphohydrolase 1) | 4.57±2.71 | 4.04±0.89 | 4.96±1.05 | 3.71±1.47 | |||
| Lama1 (laminin, alpha 1) | 1.11±0.65 | 1.36±1.32 | 0.69±0.30 | 1.78±1.56 | |||
| Lama2 (laminin, alpha 2) | 51.06±16.27 | 53.77±37.49 | 58.78±28.85 | 70.56±24.38 | |||
| Lama3 (laminin, alpha 3) | 4.51±2.05 | 4.70±3.99 | 5.13±2.18 | 8.19±7.82 | |||
| Lamb2 (laminin, beta 2) | 130.86±43.36 | 193.55±242.87 | 105.34±32.78 | 142.70±59.77 | |||
| Lamb3 (laminin, beta 3) | 2.13±0.91 | 5.96±9.21 | 3.36±3.60 | 11.55±18.73 | |||
| Lamc1 (laminin, gamma 1) | 96.26±46.52 | 74.61±26.54 | 121.24±44.02 | 96.79±45.21 | |||
| Sparc (secreted protein (osteonectin)) | 540.77±187.83 | 357.18±164.11 | 511.73±290.62 | 473.96±289.67 | |||
| Col1a1 (collagen, type I) | 110.77±74.48 | 51.29±29.09 | 89.93±45.03 | 50.24±37.26 | |||
| Col2a1 (collagen, type II) | 0.33±0.41 | 0.35±0.34 | 0.22±0.14 | 0.55±0.37 | |||
| Col3a1 (collagen, type III) | 522.01±176.67 | 362.30±162.60 | 508.44±157.25 | 356.68±136.37 | |||
| Col4a1 (collagen, type IV) | 198.74±114.41 | 124.41±60.43 | 219.44±150.38 | 176.99±143.98 | |||
| Col4a2 (collagen, type IV) | 41.49±21.29 | 29.76±17.65 | 44.60±34.00 | 33.27±21.15 | |||
| Col4a3 (collagen, type IV) | 18.87±10.43 | 14.30±9.88 | 13.87±5.27 | 22.03±16.94 | |||
| Col5a1 (collagen, type V) | 18.47±11.59 | 9.60±3.94 | 14.67±5.35 | 9.98±5.03 | |||
| Col6a1 (collagen, type VI) | 14.03±9.57 | 5.43±2.63 | 10.23±7.81 | 7.34±4.63 | |||
| Col8a1 (collagen, type VIII) | 0.28±0.15 | 0.40±0.48 | 0.16±0.09 | 0.42±0.27 | |||
| Hapln1 (hyaluronan and proteoglycan link protein 1) | 0.34±0.23 | 0.95±1.65 | 0.30±0.27 | 0.72±0.86 | |||
| Adamts1 (ADAM motif 1) | 32.03±18.77 | 28.05±29.75 | 24.30±13.22 | 22.80±9.50 | |||
| Adamts2 (ADAM motif 2) | 16.84±9.01 | 25.29±21.95 | 15.98±9.67 | 83.46±71.23 | |||
| Adamts5 (ADAM motif 5) | 28.48±11.95 | 29.39±16.68 | 38.95±13.44 | 34.34±13.01 | |||
| Adamts8 (ADAM motif 8) | 5.81±2.53 | 21.08±22.16 | 6.73±6.29 | 22.41±13.47 | |||
| Mmp1a (matrix metallopeptidase 1a) | 0.16±0.11 | 0.74±1.31 | 0.09±0.04 | 0.36±0.14 | |||
| Mmp2 (matrix metallopeptidase 2) | 37.38±19.73 | 26.66±6.11 | 35.14±7.02 | 28.07±9.29 | |||
| Mmp3 (matrix metallopeptidase 3) | 0.16±0.19 | 0.20±0.27 | 0.13±0.09 | 0.34±0.23 | |||
| Mmp7 (matrix metallopeptidase 7) | 0.67±0.36 | 1.99±2.86 | 1.06±0.97 | 1.41±1.04 | |||
| Mmp8 (matrix metallopeptidase 8) | 0.76±0.61 | 0.53±0.23 | 0.36±0.21 | 0.58±0.25 | |||
| Mmp9 (matrix metallopeptidase 9) | 7.19±5.17 | 5.78±2.63 | 4.18±3.03 | 10.26±8.73 | |||
| Mmp10 (matrix metallopeptidase 10) | 17.69±7.81 | 20.99±15.52 | 10.42±5.52 | 98.65±106.91 | |||
| Mmp11 (matrix metallopeptidase 11) | 61.56±32.37 | 23.82±12.73 | 20.40±17.17 | 56.75±43.71 | |||
| Mmp12 (matrix metallopeptidase 12) | 3.53±5.57 | 4.36±6.16 | 0.89±1.00 | 0.54±0.39 | |||
| Mmp13 (matrix metallopeptidase 13) | 0.49±0.24 | 0.65±0.47 | 0.35±0.15 | 0.85±0.54 | |||
| Mmp14 (matrix metallopeptidase 14) | 10.03±6.96 | 5.03±5.11 | 9.50±6.63 | 7.83±7.42 | |||
| Mmp15 (matrix metallopeptidase 15) | 18.41±7.96 | 11.20±7.66 | 16.45±7.83 | 30.42±23.80 | |||
| Mmp16 (matrix metallopeptidase 16) | 0.96±0.56 | 0.32±0.17 | 0.54±0.36 | 0.26±0.30 | |||
| Timp1 (TIMP metallopeptidase inhibitor 1) | 39.52±4.18 | 82.88±91.21 | 40.40±15.26 | 44.86±22.59 | |||
| Timp2 (TIMP metallopeptidase inhibitor 2) | 205.76±55.90 | 151.46±26.83 | 211.01±40.58 | 179.26±50.71 | |||
| Timp3 (TIMP metallopeptidase inhibitor 3) | 80.40±51.11 | 37.11±18.82 | 79.17±56.02 | 62.78±38.61 | |||
| Fbln1 (fibulin 1) | 25.70±18.72 | 21.83±20.66 | 19.27±11.63 | 36.36±32.56 | |||
| Spock1 (sparc/osteonectin 1) | 8.98±5.44 | 11.60±6.21 | 11.74±7.19 | 15.44±17.27 | |||
| Tnc (tenascin C) | 6.24±6.89 | 3.05±1.44 | 4.52±3.37 | 2.95±1.39 | |||
| Vcan (versican) | 20.72±9.59 | 32.96±40.49 | 19.53±8.65 | 19.74±10.78 | |||
Abbreviations: ANOVA, analysis of variance; ECM, extracellular matrix; IRON, high-iron diet/no radiation; IRON+RAD, high-iron diet/radiation; qRT-PCR, quantitative reverse transcription PCR; RAD, adequate-iron diet/radiation.
Expression level of 84 genes analyzed in the vasculature by qRT-PCR. The [(2−Δct)×1,000] values for all genes investigated in the vasculature are listed. P values are based on two-way ANOVA of the treatment effects calculated using Δct values.
Figure 4Radiation effects on gene expression in the vasculature of rats on normal-iron or high-iron diets. Relative gene expression in aortic samples, calculated using the ΔΔCt method, is presented as fold change associated with radiation (RAD versus CON groups for normal diet, IRON+RAD versus IRON groups for high-iron diet). All genes were considered to be upregulated if the relative value was above 1 and downregulated if the relative value was below 1. CON, adequate-iron diet/no radiation; IRON, high-iron diet/no radiation; RAD, adequate-iron diet/radiation.